Clinical and Translational Science Collaborative of Northern Ohio, Systems Marketing Analysis for Research Translation (SMART) Innovation Program

北俄亥俄州临床和转化科学合作组织研究转化系统营销分析 (SMART) 创新计划

基本信息

批准号：
10703736
负责人：
Brian Joseph Biroscak
金额：
$ 72.46万
依托单位：
CASE WESTERN RESERVE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-15 至 2028-06-30
项目状态：
未结题

项目摘要

PROJECT ABSTRACT The Systems Marketing Analysis for Research Translation (SMART) Innovation Program brings a cutting- edge set of tools together to improve clinical and translational research effectiveness, efficiency, and equity and thereby enhance public health and health care delivery. The SMART Innovation Program supports CTSA Program Goals by (1) developing, demonstrating, and disseminating an operational innovation that improves the efficiency and effectiveness of clinical translational, (2) a structured, participatory method for promoting partnerships and collaborations to facilitate and accelerate translational research projects local, regionally, and nationally, and (3) creating and providing this with an explicit emphasis on addressing health disparities and deliver the benefits of translational science to all. More specifically, we build on our collective prior experience and collaboration combining community based-system dynamics as a participatory method for selection and tailoring of implementation strategies with a social marketing approach within a novel set-based concurrent engineering approach borrowed from manufacturing to accelerate translational research and health equity. Our primary hypothesis is that the integration of participatory system dynamics modeling with social marketing analysis improves clinical and translational research effectiveness, efficiency, and equity by reducing the complexity of translational research. The SMART Innovation program is designed to work with clinical researchers at any stage of the translational research continuum with an emphasis on the design of implementation strategies that maximize implementation outcomes of fidelity, reach, and sustainability of clinical interventions to promote health equity. More specifically, the SMART Innovation program begins with market analysis of the end user of the innovation (e.g., patient in the case of medication adherence, provider in the case of suicide screening and referral) to characterize the initial distribution of “demand” for the clinical innovation and its potential impact on reducing health inequities. This preliminary analysis provides the basis for a 2.5-day participatory group model building workshop with clinical researchers, implementation researchers, and end-users (or proxies, e.g., a patient navigator, advocate) to conceptualize the implementation context as a system, select and tailor implementation strategies, and refine an implementation. The program then supports the refinement of the analysis through a second phase of marketing analysis, leading to a more efficient translation of clinical and community innovations to improve health outcomes and health equity.

项目摘要研究翻译的系统营销分析（SMART）创新计划带来了挑战 - 一组工具共同提高临床和翻译的研究效率，效率和公平性从而增强公共卫生和保健提供。智能创新计划支持CTSA 通过（1）开发，演示和传播一项进步的运营创新，通过（1）进行计划目标临床翻译的效率和有效性，（2）一种促进的结构化参与方法合作伙伴关系和合作，以促进和加速翻译研究项目，当地，区域和在全国范围内，以及（3）创建和提供这一点，以明确的重视解决健康分配和将转化科学的好处交给所有人。更具体地说，我们以我们的集体先验经验为基础以及将基于社区的系统动态结合为选择的参与方法和合作在新型基于集合的并发中使用社会营销方法来量身定制实施策略从制造业到加速转化研究和健康公平的工程方法。我们的主要假设是参与系统动态建模与社会营销的整合分析通过降低临床和翻译的研究有效性，效率和公平性翻译研究的复杂性。智能创新计划旨在与临床研究人员合作翻译研究继续着重于最大化实施策略的设计临床干预措施的忠诚度，覆盖范围和可持续性以促进健康公平的实施结果。更具体地说，智能创新计划始于对创新的最终用户的市场分析（例如，在药物依从性的情况下，自杀筛查和转诊的提供者）表征临床创新的“需求”初始分布及其对减少的潜在影响健康不平等。此初步分析为2.5天的参与小组模型建设提供了基础与临床研究人员，实施研究人员和最终用户的研讨会（或代理，例如患者 Navigator，倡导者）将实现上下文概念化为系统，选择和量身定制实现策略，并完善实施。然后，该程序通过营销分析的第二阶段，导致更有效地翻译临床和社区改善健康成果和健康公平的创新。